Pain Medicine, Interventional Pain Medicine · Irving, TX
NPI
1639373129
Since 2007
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6750 N Macarthur Blvd, Suite 255
Irving, TX, 75039
Phone (972) 823-3240
Groups this clinician bills Medicare through
Medicare paid, 2024
$451K
18,662 services
Medicare patients, 2024
418
Average age 72
Drug cost, 2024
$1.4M
13,672 prescriptions
Company payments, 2025
$2,612
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Whitney L Chouteau was code J0585 (injection, onabotulinumtoxina, 1 unit), 7,506 times for 14 patients. In total Whitney L Chouteau billed 18,662 services in 68 codes, and Medicare paid $451K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 7,506 | 14 | $4.86 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,487 | 356 | $12.31 | $18K |
| 99213 Office E&M - Established | Office | 1,441 | 329 | $64.27 | $93K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 982 | 96 | $0.75 | $733 |
| 96138 Behavioral Health Services | Office | 724 | 226 | $26.98 | $20K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 676 | 95 | $48.48 | $33K |
| 98977 Pulmonary Function Testing | Office | 424 | 132 | $36.37 | $15K |
| 98980 Care Management/Coordination | Office | 421 | 125 | $39.39 | $17K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 400 | 191 | $110.12 | $44K |
| 80307 Drug Tests | Office | 399 | 190 | $59.80 | $24K |
| 98981 Care Management/Coordination | Office | 391 | 124 | $31.13 | $12K |
| 99214 Office E&M - Established | Office | 308 | 171 | $95.08 | $29K |
| 96127 Behavioral Health Services | Office | 198 | 49 | $3.05 | $605 |
| 98975 Pulmonary | Office | 96 | 94 | $15.70 | $1,507 |
| 99204 Office E&M - New | Office | 75 | 75 | $121.57 | $9,118 |
By year: 2022 $548K for 12,984 services; 2023 $551K for 15,061 services; 2024 $451K for 18,662 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 400 | 191 | $110.12 | $44K |
| 80307 Drug Tests | 399 | 190 | $59.80 | $24K |
Medicare prescription drug claims, 2024
In 2024, the drug Whitney L Chouteau prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,350 prescriptions and refills. In total Whitney L Chouteau wrote 13,672 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,350 | 3,351 | 385 | $114K |
| Gabapentin Generic | 927 | 1,403 | 224 | $17K |
| Morphine Sulfate Er Morphine Sulfate | 823 | 823 | 82 | $25K |
| Oxycodone Hcl Generic | 806 | 807 | 94 | $16K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 771 | 771 | 103 | $27K |
| Pregabalin Generic | 627 | 797 | 123 | $16K |
| Tizanidine Hcl Generic | 556 | 726 | 112 | $6,291 |
| Cyclobenzaprine Hcl Generic | 482 | 594 | 106 | $24K |
| Methocarbamol Generic | 423 | 502 | 104 | $5,592 |
| Buprenorphine Generic | 394 | 394 | 60 | $121K |
| Tramadol Hcl Generic | 373 | 373 | 69 | $3,094 |
| Lidocaine Generic | 354 | 533 | 63 | $69K |
| Xtampza Er Oxycodone Myristate | 317 | 317 | 36 | $152K |
| Hydromorphone Hcl Generic | 205 | 205 | 28 | $3,880 |
| Methadone Hcl Generic | 200 | 200 | 22 | $4,336 |
Brand drugs: 1,405 claims; generic drugs: 12,267 claims; opioid claims: 7,985.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Whitney L Chouteau $2,612 ($2,612 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $412.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $412 |
| Forte Bio-Pharma LLC | 26 | $337 |
| Collegium Pharmaceutical, Inc. COLL | 25 | $298 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $202 |
| Protega Pharmaceutials Inc | 9 | $186 |
| Medtronic, Inc. MDT | 3 | $182 |
| Pfizer Inc. PFE | 7 | $133 |
| Scilex Pharmaceuticals Inc. | 6 | $102 |
| Nalu Medical, Inc. | 3 | $89.02 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $87.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.